| Soluble receptor activator of nuclear factor κB ligand–osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index E Terpos, R Szydlo, JF Apperley, E Hatjiharissi, M Politou, J Meletis, ... Blood 102 (3), 1064-1069, 2003 | 506 | 2003 |
| Treatment of Waldenstrom’s macroglobulinemia with rituximab MA Dimopoulos, C Zervas, A Zomas, C Kiamouris, NA Viniou, V Grigoraki, ... Journal of Clinical Oncology 20 (9), 2327-2333, 2002 | 295 | 2002 |
| High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents E Terpos, E Katodritou, M Roussou, A Pouli, E Michalis, S Delimpasi, ... European journal of haematology 85 (2), 114-119, 2010 | 159 | 2010 |
| Treatment of Waldenstrom’s macroglobulinemia with thalidomide MA Dimopoulos, A Zomas, NA Viniou, V Grigoraki, E Galani, C Matsouka, ... Journal of clinical oncology 19 (16), 3596-3601, 2001 | 146 | 2001 |
| Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients E Terpos, A Mougiou, A Kouraklis, A Chatzivassili, E Michalis, ... British journal of haematology 118 (1), 174-180, 2002 | 142 | 2002 |
| Recurrent ETNK1 mutations in atypical chronic myeloid leukemia CB Gambacorti-Passerini, C Donadoni, A Parmiani, A Pirola, S Redaelli, ... Blood, The Journal of the American Society of Hematology 125 (3), 499-503, 2015 | 126 | 2015 |
| Prognostic evaluation of the microvascular network in myelodysplastic syndromes P Korkolopoulou, E Apostolidou, PM Pavlopoulos, N Kavantzas, N Vyniou, ... Leukemia 15 (9), 1369-1376, 2001 | 122 | 2001 |
| Tartrate‐resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma E Terpos, J de la Fuente, R Szydlo, E Hatjiharissi, N Viniou, J Meletis, ... International journal of cancer 106 (3), 455-457, 2003 | 113 | 2003 |
| Significance of macrophage inflammatory protein-1 alpha (MIP-1α) in multiple myeloma E Terpos, M Politou, N Viniou, A Rahemtulla Leukemia & lymphoma 46 (12), 1699-1707, 2005 | 105 | 2005 |
| Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first … MA Dimopoulos, A Pouli, K Zervas, V Grigoraki, A Symeonidis, ... Annals of oncology 14 (7), 1039-1044, 2003 | 100 | 2003 |
| Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study P Korkolopoulou, N Viniou, N Kavantzas, E Patsouris, I Thymara, ... Leukemia 17 (1), 89-97, 2003 | 100 | 2003 |
| Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma E Terpos, J Palermos, K Tsionos, K Anargyrou, N Viniou, P Papassavas, ... European journal of haematology 65 (5), 331-336, 2000 | 89 | 2000 |
| Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 … E Katodritou, E Terpos, AS Symeonidis, A Pouli, C Kelaidi, MC Kyrtsonis, ... American journal of hematology 89 (8), 803-808, 2014 | 81 | 2014 |
| Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma TP Vassilakopoulos, MK Angelopoulou, N Constantinou, T Karmiris, ... Blood 105 (5), 1875-1880, 2005 | 77 | 2005 |
| Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin‐6 and β2‐microglobulin in multiple myeloma E Terpos, N Viniou, J De La Fuente, J Meletis, E Voskaridou, ... European journal of haematology 70 (1), 34-42, 2003 | 74 | 2003 |
| Cardiovascular hypertensive emergencies DP Papadopoulos, EA Sanidas, NA Viniou, V Gennimata, V Chantziara, ... Current hypertension reports 17, 1-6, 2015 | 59 | 2015 |
| Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML L Adès, L Girshova, VA Doronin, M Díez-Campelo, D Valcárcel, ... Blood advances 6 (17), 5132-5145, 2022 | 55 | 2022 |
| Comparison of allogeneic stem cell transplantation, high‐dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de … AM Tsimberidou, N Stavroyianni, N Viniou, M Papaioannou, M Tiniakou, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2003 | 54 | 2003 |
| Origin and diversification of the clonogenic cell in multiple myeloma: lessons from the immunoglobulin repertoire C Kosmas, K Stamatopoulos, N Stavroyianni, K Zoi, C Belessi, N Viniou, ... Leukemia 14 (10), 1718-1726, 2000 | 43 | 2000 |
| Apelin and visfatin plasma levels in healthy individuals with high normal blood pressure CI Liakos, EA Sanidas, DN Perrea, CA Grassos, V Chantziara, NA Viniou, ... American journal of hypertension 29 (5), 549-552, 2016 | 41 | 2016 |
